The North America Adhesion Barrier Market would witness market growth of 6.4% CAGR during the forecast period (2023-2030).
A medical implant termed as adhesion barrier can minimize abnormal internal scarring brought on by adhesions while the internal tissues and organs are still recovering from surgery. It involves a precise surgical technique crucial for reducing adhesion formation. The market's primary growth factors are an aging population and increased surgical procedures.
The market is expected to surge due to the frequency of invasive surgeries with a significant risk of postoperative complications. The market will also advance due to the expansion of trauma care centers and improvements in the healthcare infrastructure. In addition, the rising number of sports-related injuries is anticipated to fuel market expansion.
Enhanced availability of healthcare services and increased awareness of available treatment options have resulted in a rise in patients seeking surgical treatment for their medical conditions. Certain chronic conditions, including diabetes, heart disease, and certain cancers, may require surgical procedures for diagnosis, treatment, or management. Recovery periods for minimally invasive surgeries are typically shorter than those for traditional open surgeries.
According to Canadian Cancer Statistics, 45% of Canadian men and 43% of Canadian women will develop cancer during their lifetimes. Similarly, according to Globocan 2020, Mexico had a total of 195499 new cancer cases. A total of 29,929 (15.3%), 26,742 (13.7%), and 14,901 (7.6%) of these cases were breast, prostate, and colorectal cancers. As a result of the increasing number of cancer cases, more procedures will be needed for treatment. The need for an adhesion barrier would increase along with the increase of procedures due to the increased chances of adhesion formation. Consequently, the market is anticipated to expand in the region.
The US market dominated the North America Adhesion Barrier Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $288.3 million by 2030. The Canada market is experiencing a CAGR of 8.8% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 7.9% during (2023 - 2030).
Based on Application Area, the market is segmented into General/Abdominal Surgeries, Orthopedic Surgeries, Gynecological Surgeries, Cardiovascular Surgeries, Urological Surgeries, Neurological Surgeries, Reconstructive Surgeries, and Others. Based on Formulation, the market is segmented into Film Formulations, Gel Formulations, and Liquid Formulations. Based on Product, the market is segmented into Synthetic Products (Hyaluronic Acid, Regenerated Cellulose, Polyethylene Glycol, and Others), and Natural Products. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Adhesion Barrier Market is Projected to reach USD 1.2 Billion by 2030, at a CAGR of 7.2%
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Sanofi S.A., Becton Dickinson and Company, Baxter International, Inc.(Hill-Rom Holdings, Inc.), Johnson & Johnson, Anika Therapeutic, Inc., FzioMed, Inc., MAST Biosurgery USA, Inc.(MAST Biosurgery AG), Innocoll Biotherapeutics N.A. Inc., Luna Innovations, Incorporated and Integra LifeSciences Holdings Corporation.
By Application Area
By Formulation
By Product
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
